Nephrolithiasis in pediatric hematopoietic cell transplantation with up to 40 years of follow‐up

Kidney stones have been reported to occur after childhood cancer, but little is known about kidney stones in children following hematopoietic cell transplantation (HCT). The objective of this retrospective study was to determine risk factors for the development of kidney stones and to describe the prevalence among survivors.

[1]  K. Ness,et al.  Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia , 2012, Journal of Cancer Survivorship.

[2]  A. Rule,et al.  Temporal trends in incidence of kidney stones among children: a 25-year population based study. , 2012, The Journal of urology.

[3]  Christopher S Saigal,et al.  Prevalence of kidney stones in the United States. , 2012, European urology.

[4]  P. Auquier,et al.  Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia , 2011 .

[5]  B. Storer,et al.  Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  C. Pui,et al.  Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia , 2009, Leukemia.

[7]  K. Ness,et al.  High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation , 2009, Bone Marrow Transplantation.

[8]  T. Salmi,et al.  Long‐term follow‐up of renal function after high‐dose methotrexate treatment in children , 2008, Pediatric blood & cancer.

[9]  A. Luke,et al.  Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  M. Sorror,et al.  Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens , 2008, Bone Marrow Transplantation.

[11]  Y. Shiozawa,et al.  UROLITHIASIS IN AN ACUTE LYMPHOBLASTIC LEUKEMIA CHILD DURING INDUCTION CHEMOTHERAPY , 2008, Pediatric hematology and oncology.

[12]  G. Curhan.  Epidemiology of stone disease. , 2007, The Urologic clinics of North America.

[13]  B. Storer,et al.  Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  N. Weiss,et al.  Chronic kidney disease in long-term survivors of hematopoietic cell transplant , 2007, Bone Marrow Transplantation.

[15]  M. Sorror,et al.  Serious Acute or Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplantation: A Comparison of Myeloablative and Non-Myeloablative Conditioning Regimens. , 2006 .

[16]  T. Gooley,et al.  Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia , 2004, Bone Marrow Transplantation.

[17]  B. Rosner,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .

[18]  National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents , 2004, Pediatrics.

[19]  M. Akahoshi,et al.  Noncancer Disease Incidence in Atomic Bomb Survivors, 1958–1998 , 2004, Radiation research.

[20]  H. Deeg,et al.  Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[21]  M. Flowers,et al.  Diagnosis and clinical management of chronic graft-versus-host disease , 2004, International journal of hematology.

[22]  B. Storer,et al.  Diabetes Mellitus in Long-Term Survivors of Pediatric Hematopoietic Cell Transplantation , 2004, Journal of pediatric hematology/oncology.

[23]  A. Tichelli,et al.  Nonmalignant late effects after allogeneic stem cell transplantation. , 2003, Blood.

[24]  C. Pui,et al.  Urolithiasis in pediatric patients with acute lymphoblastic leukemia , 2003, Leukemia.

[25]  H. Deeg,et al.  Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. , 2002, Blood.

[26]  V. Braun,et al.  Urinary infection stones. , 2002, International journal of antimicrobial agents.

[27]  Shumei S. Guo,et al.  2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.

[28]  B. Storer,et al.  Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. , 2002, Blood.

[29]  Shumei S. Guo,et al.  CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000 , 2002 .

[30]  J. Fay,et al.  Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. , 2000, Blood.

[31]  T. Meschi,et al.  Essential arterial hypertension and stone disease. , 1999, Kidney international.

[32]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[33]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. , 1998, WMJ : official publication of the State Medical Society of Wisconsin.

[34]  H. Deeg,et al.  Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial. , 1997, Blood.

[35]  K. Sullivan,et al.  Unrelated donor marrow transplantation in children. , 1995, Blood.

[36]  S. Bonsib,et al.  Radiation nephropathy: a review. , 1995, Scanning microscopy.

[37]  H. Deeg,et al.  Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. , 1994, Blood.

[38]  R. Storb,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. , 1990, Blood.

[39]  K. Sullivan,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. , 1990, Blood.

[40]  H. Deeg,et al.  Graft‐versus‐host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long‐term follow‐up of a controlled trial , 1989, British journal of haematology.

[41]  C. Pui,et al.  Urolithiasis in childhood acute leukemia and nonHodgkin's lymphoma. , 1986, The Journal of urology.

[42]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.

[43]  R Storb,et al.  Bone-marrow transplantation (second of two parts). , 1975, The New England journal of medicine.

[44]  R Storb,et al.  Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.